DocMorris

DocMorris has set the final terms for the newly issued convertible bond maturing in 2031: the conversion price is CHF 13.83 per share (conversion premium 32.5% versus the reference price of CHF 10.4374). The issue volume is CHF 96.8 million and was significantly oversubscribed by institutional investors. The maturity was extended from 2028 to 2031, the coupon was cut from 3.0% to 1.5%, and the number of underlying shares was reduced from 7.6 million to 7.0 million. The proceeds are intended for general corporate purposes. » More on finanzen.net

DocMorris has successfully completed a privately placed convertible bond maturing in 2031. The volume is around CHF 100 million with a coupon of 1.5% and a conversion premium of 32.5% versus the reference price. The proceeds will be used to repurchase the 2028 convertible bond and for general corporate purposes, thereby extending the maturity profile to 2031. The number of underlying shares for the outstanding 2028 convertibles has been reduced from 7.6 million to 7.0 million. » More on finanzen.net

DocMorris is launching a private placement of around CHF 100 million of senior, unsecured convertible bonds maturing in 2031 to finance the early repurchase of the 2028 convertible bond. The transaction extends the maturity, lowers the coupon to an expected 1.5–2.0% and reduces potential share dilution from 7.6 to 7.0 million shares while significantly increasing the conversion price. The new bonds will be offered to professional investors in Switzerland and outside Switzerland and are to be implemented, among other measures, through bilateral buybacks of existing holders of the 2028 convertible bond. » More on de.investing.com